Skip to main content

Revvityブログ

発見から治療までのイノベーションを促進

The significance of longitudinal in vivo imaging in advancing drug discovery.
Small Molecule Drug Discovery November 8, 2024 - 3 min read
Reproductive Health
Uniting for early detection: the role of Revvity in DMD screening.
Reproductive Health
Building tomorrow - the professional journey of an SMA scientist.
NGS
Challenges in analyzing data with UMI-UDIs in next-generation sequencing.
Automation
Partnering with purpose: collaboration with Australian Organoid Facility.
Drug Development, Small Molecule Drug Discovery
How to leverage automation of tissue homogenization to address sample prep challenges in drug discovery & development.
Physiological Models
Revolutionizing drug safety: tools reshaping toxicology.
Physiological Models
Integrating live-cell imaging with optimized organoid pipelines for prostate cancer drug testing.
Cell and Gene Therapy
Advancing allogeneic cell therapy: unleashing the power of an innovative base editing tool.
Automation
A glimpse into forensic toxicology analysis of opioids: new method development.
Disease Research
High-content imaging siRNA screens identify trafficking factors in Alphavirus infection.

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ